Skip to main content
. Author manuscript; available in PMC: 2022 Nov 14.
Published in final edited form as: AJOB Empir Bioeth. 2021 Oct 1;12(4):266–275. doi: 10.1080/23294515.2021.1983667

Table 1.

Six hypothetical Patients.

A 91-year-old retired doctor with a past medical history of coronary artery disease, history of stroke 10 years ago with no residual disease. SOFA: 6
B 65-year-old retired daycare teacher with a past medical history of poorly controlled diabetes. SOFA: 7
C 45-year-old ED nurse with active breast cancer (receiving chemotherapy with curative intent) and is currently immunocompromised. SOFA: 11
D 35-year-old city bus driver with stage IV lung cancer, participating in clinical trial for lung cancer through the medical center where he receives care. SOFA: 12
E 25-year-old graduate student with hypertension, 30 weeks pregnant. SOFA: 14
F 12-year-old with a past medical history of hypoxic ischemic encephalopathy resulting in severe cognitive disabilities and severe asthma. she does not speak, is wheelchair bound, and communicates with her family by smiling. her mother is a physician. SOFA: 3, PELOD-2: 8, pSOFA: 5, estimated mortality <5%

SOFA Sequential Organ Failure Assessment; PELOD-2 Pediatric Logistic Organ Dysfunction-2; Pediatric Sequential Organ Failure Assessment.